Selecting genetic lesions with essential function for patients' leukaemia in vivo as targets for precision medicine

Project Information

LeukaemiaTargeted

Grant agreement ID: 681524

DOI 10.3030/681524

Project closed

EC signature date 25 July 2016

Start date 1 August 2016

End date 31 July 2021

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 1 945 818,00

EU contribution € 1 945 818,00

Coordinated by

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Germany